Form D · Pharmaceuticals
CTI SCIENCE, INC.
Lexington, KY · CIK 0001431739
Offering snapshot reported Jan 16, 2014 · SEC filing
- Reported sold
- $271K Offering amount: $5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 4, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 16, 2014 | Initial | $271,000 | No comparison | 4 | SEC filing |
| Oct 31, 2013 | Amendment | $3,702,210 | $3,632,210vs Aug 29, 2011 | 15 | SEC filing |
| Aug 29, 2011 | Initial | $70,000 | No comparison | 2 | SEC filing |
| Oct 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-210257
Source: Form D, filed Jan 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Boyd E. Haley | Director, Executive, Promoter |
| Ragnar Klingberg | Director, Executive |
| John M. Mc Michael | Director |
| Gerard O'gorman | Director |
| J. Todd Renner | Director, Executive |
| Kathryn M. Wachsman | Director, Executive |
| Kathryn M. Waschman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2430 Palumbo Drive Suite 140
Lexington, KY, 40509-1117
Lexington, KY, 40509-1117